LAKE OSWEGO, Ore., Dec. 19, 2025 /PRNewswire/ — Soin Neuroscience and BIOTRONIK Neuro today announced a research collaboration to advance personalized spinal cordLAKE OSWEGO, Ore., Dec. 19, 2025 /PRNewswire/ — Soin Neuroscience and BIOTRONIK Neuro today announced a research collaboration to advance personalized spinal cord

Soin Neuroscience and BIOTRONIK Neuro Announce Research Collaboration to Advance Novel Waveforms and Personalized Spinal Cord Stimulation Tuning

LAKE OSWEGO, Ore., Dec. 19, 2025 /PRNewswire/ — Soin Neuroscience and BIOTRONIK Neuro today announced a research collaboration to advance personalized spinal cord stimulation (SCS) tuning using Soin Neuroscience’s proprietary waveform technology.

Led by Amol Soin, M.D., Founder and CEO of Soin Neuroscience, the collaboration will evaluate Soin’s new methods of stimulation optimization. This research initiative is designed to assess Soin’s novel adaptive programming strategies, waveforms, and algorithms informed by observed therapy responses, with the goal of improving patient outcomes in the management of chronic pain.

“While spinal cord stimulation is an established therapy, variability in individual patient response remains a significant challenge,” said Dr. Soin. “Building upon years of prior research, this collaboration allows us to further investigate personalized stimulation tuning approaches using our new waveforms that incorporate iterative optimization and advanced programming flexibility to better align therapy with each patient’s unique needs.”

The Prospera SCS System provides a versatile platform for advanced therapy programming through its BioArc stimulation engine and remote programming capabilities, which support proprietary programming strategies and enable investigation of novel therapy paradigms.

“We are pleased to collaborate with Soin Neuroscience on this important research initiative,” said Todd Langevin, President at BIOTRONIK Neuro. “This work reflects our continued commitment to advancing neuromodulation science and expanding the potential of personalized therapy approaches in support of successful SCS outcomes.”

About Soin Neuroscience
Soin Neuroscience is a medical device company that has developed its own spinal cord stimulation waveforms, algorithms, devices, systems, and other neuromodulation technologies. These technologies are for investigational use only.

About BIOTRONIK Neuro

BIOTRONIK Neuro is a division of BIOTRONIK, a leading medical device company that has been improving the lives of patients with heart diseases for decades. Leveraging BIOTRONIK’s advanced cardiovascular technologies, BIOTRONIK Neuro has created a new approach to spinal cord stimulation (SCS) therapy management: one that’s not just implanted, but truly connected to the needs of patients and providers. Our goal is to redefine relief for patients experiencing chronic pain and to optimize the SCS experience daily, and over the lifetime of patient therapy. BIOTRONIK Neuro is based in Lake Oswego, Oregon.

About BIOTRONIK

For over 60 years, BIOTRONIK has stood at the forefront of medical technology, pioneering breakthrough innovations that are transforming the lives of millions affected by heart disease and chronic pain. Rooted in a deep purpose to seamlessly harmonize technology with the human body, we engineer trusted, life-changing therapies through our advanced active implants in Cardiac Rhythm Management, Monitoring, and Neuromodulation, while providing cutting-edge solutions in Electrophysiology. From creating Germany’s first pacemaker in 1963 to breaking new ground in digital technologies and Conduction System Pacing today, BIOTRONIK is continuously raising the bar for quality, performance, and innovation. Headquartered in Berlin, our global reach spans over 100 countries across the Americas, EMEA, and Asia—bringing bold, future-ready solutions that are shaping the next generation of medical technology. 

For inquiries, contact: 
Beth Richman
(312) 806-8999

Corporate Communications
press@biotronik.com
+49 (0) 30 68905-1414

Cision View original content:https://www.prnewswire.com/news-releases/soin-neuroscience-and-biotronik-neuro-announce-research-collaboration-to-advance-novel-waveforms-and-personalized-spinal-cord-stimulation-tuning-302646471.html

SOURCE BIOTRONIK Neuro

Market Opportunity
NeuroWeb AI Logo
NeuroWeb AI Price(NEURO)
$0.0108
$0.0108$0.0108
0.00%
USD
NeuroWeb AI (NEURO) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Building a DEXScreener Clone: A Step-by-Step Guide

Building a DEXScreener Clone: A Step-by-Step Guide

DEX Screener is used by crypto traders who need access to on-chain data like trading volumes, liquidity, and token prices. This information allows them to analyze trends, monitor new listings, and make informed investment decisions. In this tutorial, I will build a DEXScreener clone from scratch, covering everything from the initial design to a functional app. We will use Streamlit, a Python framework for building full-stack apps.
Share
Hackernoon2025/09/18 15:05
Which DOGE? Musk's Cryptic Post Explodes Confusion

Which DOGE? Musk's Cryptic Post Explodes Confusion

A viral chart documenting a sharp decline in U.S. federal employment during President Trump's second term has sparked unexpected confusion in cryptocurrency markets
Share
Coinstats2025/12/20 01:13
Google's AP2 protocol has been released. Does encrypted AI still have a chance?

Google's AP2 protocol has been released. Does encrypted AI still have a chance?

Following the MCP and A2A protocols, the AI Agent market has seen another blockbuster arrival: the Agent Payments Protocol (AP2), developed by Google. This will clearly further enhance AI Agents' autonomous multi-tasking capabilities, but the unfortunate reality is that it has little to do with web3AI. Let's take a closer look: What problem does AP2 solve? Simply put, the MCP protocol is like a universal hook, enabling AI agents to connect to various external tools and data sources; A2A is a team collaboration communication protocol that allows multiple AI agents to cooperate with each other to complete complex tasks; AP2 completes the last piece of the puzzle - payment capability. In other words, MCP opens up connectivity, A2A promotes collaboration efficiency, and AP2 achieves value exchange. The arrival of AP2 truly injects "soul" into the autonomous collaboration and task execution of Multi-Agents. Imagine AI Agents connecting Qunar, Meituan, and Didi to complete the booking of flights, hotels, and car rentals, but then getting stuck at the point of "self-payment." What's the point of all that multitasking? So, remember this: AP2 is an extension of MCP+A2A, solving the last mile problem of AI Agent automated execution. What are the technical highlights of AP2? The core innovation of AP2 is the Mandates mechanism, which is divided into real-time authorization mode and delegated authorization mode. Real-time authorization is easy to understand. The AI Agent finds the product and shows it to you. The operation can only be performed after the user signs. Delegated authorization requires the user to set rules in advance, such as only buying the iPhone 17 when the price drops to 5,000. The AI Agent monitors the trigger conditions and executes automatically. The implementation logic is cryptographically signed using Verifiable Credentials (VCs). Users can set complex commission conditions, including price ranges, time limits, and payment method priorities, forming a tamper-proof digital contract. Once signed, the AI Agent executes according to the conditions, with VCs ensuring auditability and security at every step. Of particular note is the "A2A x402" extension, a technical component developed by Google specifically for crypto payments, developed in collaboration with Coinbase and the Ethereum Foundation. This extension enables AI Agents to seamlessly process stablecoins, ETH, and other blockchain assets, supporting native payment scenarios within the Web3 ecosystem. What kind of imagination space can AP2 bring? After analyzing the technical principles, do you think that's it? Yes, in fact, the AP2 is boring when it is disassembled alone. Its real charm lies in connecting and opening up the "MCP+A2A+AP2" technology stack, completely opening up the complete link of AI Agent's autonomous analysis+execution+payment. From now on, AI Agents can open up many application scenarios. For example, AI Agents for stock investment and financial management can help us monitor the market 24/7 and conduct independent transactions. Enterprise procurement AI Agents can automatically replenish and renew without human intervention. AP2's complementary payment capabilities will further expand the penetration of the Agent-to-Agent economy into more scenarios. Google obviously understands that after the technical framework is established, the ecological implementation must be relied upon, so it has brought in more than 60 partners to develop it, almost covering the entire payment and business ecosystem. Interestingly, it also involves major Crypto players such as Ethereum, Coinbase, MetaMask, and Sui. Combined with the current trend of currency and stock integration, the imagination space has been doubled. Is web3 AI really dead? Not entirely. Google's AP2 looks complete, but it only achieves technical compatibility with Crypto payments. It can only be regarded as an extension of the traditional authorization framework and belongs to the category of automated execution. There is a "paradigm" difference between it and the autonomous asset management pursued by pure Crypto native solutions. The Crypto-native solutions under exploration are taking the "decentralized custody + on-chain verification" route, including AI Agent autonomous asset management, AI Agent autonomous transactions (DeFAI), AI Agent digital identity and on-chain reputation system (ERC-8004...), AI Agent on-chain governance DAO framework, AI Agent NPC and digital avatars, and many other interesting and fun directions. Ultimately, once users get used to AI Agent payments in traditional fields, their acceptance of AI Agents autonomously owning digital assets will also increase. And for those scenarios that AP2 cannot reach, such as anonymous transactions, censorship-resistant payments, and decentralized asset management, there will always be a time for crypto-native solutions to show their strength? The two are more likely to be complementary rather than competitive, but to be honest, the key technological advancements behind AI Agents currently all come from web2AI, and web3AI still needs to keep up the good work!
Share
PANews2025/09/18 07:00